363 related articles for article (PubMed ID: 28557602)
1. Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.
Fabiani C; Vitale A; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Favale RA; Fusco F; Franceschini R; Frediani B; Iannone F; Galeazzi M; Tosi GM; Cantarini L
J Ocul Pharmacol Ther; 2017 Sep; 33(7):549-555. PubMed ID: 28557602
[TBL] [Abstract][Full Text] [Related]
2. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
Khurana RN; Porco TC
Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Intravitreal Dexamethasone Implant for Refractory Uveitic Macular Edema in Adults and Children.
Ratra D; Barh A; Banerjee M; Ratra V; Biswas J
Ocul Immunol Inflamm; 2018; 26(7):1034-1040. PubMed ID: 29394119
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of an intravitreal dexamethasone implant for the treatment of noninfectious uveitic macular edema.
Habot-Wilner Z; Sorkin N; Goldenberg D; Loewenstein A; Goldstein M
Ophthalmologica; 2014; 232(2):77-82. PubMed ID: 25012541
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series.
Larochelle MB; Smith J; Dacey MS
Am J Ophthalmol; 2016 Jun; 166():149-153. PubMed ID: 27066725
[TBL] [Abstract][Full Text] [Related]
6. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.
Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A
Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.
Nobre-Cardoso J; Champion E; Darugar A; Fel A; Lehoang P; Bodaghi B
Ocul Immunol Inflamm; 2017 Aug; 25(4):447-454. PubMed ID: 27003221
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone Inserts in Noninfectious Uveitis: A Single-Center Experience.
Pohlmann D; Vom Brocke GA; Winterhalter S; Steurer T; Thees S; Pleyer U
Ophthalmology; 2018 Jul; 125(7):1088-1099. PubMed ID: 29459041
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal Dexamethasone Implant for the Treatment of Macular Edema in Chronic Non-infectious Uveitis.
Tsang AC; Virgili G; Abtahi M; Gottlieb CC
Ocul Immunol Inflamm; 2017 Oct; 25(5):685-692. PubMed ID: 27191685
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease.
Fabiani C; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Franceschini R; Frediani B; Iannone F; Marco Tosi G; Rigante D; Cantarini L
Isr Med Assoc J; 2017 Jul; 19(7):415-419. PubMed ID: 28786255
[TBL] [Abstract][Full Text] [Related]
11. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
12. Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.
Tomkins-Netzer O; Lightman S; Drye L; Kempen J; Holland GN; Rao NA; Stawell RJ; Vitale A; Jabs DA;
Ophthalmology; 2015 Nov; 122(11):2351-9. PubMed ID: 26359188
[TBL] [Abstract][Full Text] [Related]
13. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis.
Hasanreisoğlu M; Özdemir HB; Özkan K; Yüksel M; Aktaş Z; Atalay HT; Özdek Ş; Gürelik G
Turk J Ophthalmol; 2019 Oct; 49(5):250-257. PubMed ID: 31650791
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
Kong X; Psaras C; Stewart JM
Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
[TBL] [Abstract][Full Text] [Related]
18. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome.
Dutra Medeiros M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3320-4. PubMed ID: 23599334
[TBL] [Abstract][Full Text] [Related]
20. Response of Postoperative and Chronic Uveitic Cystoid Macular Edema to a Dexamethasone-Based Intravitreal Implant (Ozurdex).
Garweg JG; Baglivo E; Freiberg FJ; Pfau M; Pfister IB; Michels S; Zandi S
J Ocul Pharmacol Ther; 2016 Sep; 32(7):442-50. PubMed ID: 27479780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]